For one additional patient, surgery was indicated after the observation of a doubling of serum Tg level in six months (from 172 ng/mL to 320 ng/mL) associated with a posterior tumor localization adjacent to the trachea, for whom active surveillance was previously agreed upon due to a high surgical risk (Figures 3 and 4). The gene discussed is TG; the disease is neoplasm.